Last summer, the Trump administration, physician advocates, public health academics and activists urged commercial health insurers to streamline the prior authorization process, and major companies signed a six-part pledge to reduce it. Critics contend that prior authorization is just one of many denial-of-care tools that create a float—delaying payments and letting insurers invest premium cash for profit, often at the expense of patients.